Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Calcitriol may help prostate cancer cells develop into normal cells. Zoledronate
may delay or prevent the formation of bone metastases. Combining calcitriol and zoledronate
may be an effective treatment for progressive prostate cancer.
PURPOSE: Phase I trial to study the effectiveness of combining calcitriol with zoledronate in
treating patients who have progressive prostate cancer.